cbdMD (YCBD) Other Non-Current Liabilities (2018 - 2023)
cbdMD (YCBD) posted Other Non-Current Liabilities of $20611.0 for Q4 2023, down 77.19% sequentially from $90363.0 in Q3 2023, and down 87.2% YoY from $161000.0 in Q4 2022.
cbdMD (YCBD) Other Non-Current Liabilities (2018 - 2023) Analysis & Trends
cbdMD has reported Other Non-Current Liabilities for 6 years, with the latest figure at $20611.0 in Q4 2023.
- Quarterly Other Non-Current Liabilities fell 87.2% year-over-year to $20611.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $20611.0 (down 87.2% YoY) and the FY2023 annual result came in at $90363.0, down 67.26% from the prior year.
- Other Non-Current Liabilities slipped to $20611.0 in Q4 2023 per YCBD's latest filing, from $90363.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $102.3 million in Q1 2019 and troughed at $13000.0 in Q1 2022.
- A 5-year average of $15.8 million and a median of $276000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities plunged 99.94% in 2022, then jumped 1184.62% in 2023.
- Over 5 years, Other Non-Current Liabilities stood at $33.7 million in 2019, then sank by 51.93% to $16.2 million in 2020, then tumbled by 99.01% to $161000.0 in 2021, then changed by 0.0% to $161000.0 in 2022, then slumped by 87.2% to $20611.0 in 2023.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $20611.0, $90363.0, and $122230.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 20,611.00 |
| Sep 30, 2023 | 90,363.00 |
| Jun 30, 2023 | 122,230.00 |
| Mar 31, 2023 | 167,000.00 |
| Dec 31, 2022 | 161,000.00 |
| Sep 30, 2022 | 276,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 161,000.00 |
| Sep 30, 2021 | 9.86 Mn |
| Jun 30, 2021 | 920,000.00 |
| Mar 31, 2021 | 22.30 Mn |
| Sep 30, 2020 | 16.20 Mn |
| Dec 31, 2019 | 33.70 Mn |
| Sep 30, 2019 | 50.60 Mn |
| Mar 31, 2019 | 102.27 Mn |
| Dec 31, 2018 | 71.35 Mn |
| Jun 30, 2018 | 8,004.00 |